1. Home
  2. CRMD vs TXO Comparison

CRMD vs TXO Comparison

Compare CRMD & TXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRMD
  • TXO
  • Stock Information
  • Founded
  • CRMD 2006
  • TXO 2012
  • Country
  • CRMD United States
  • TXO United States
  • Employees
  • CRMD N/A
  • TXO N/A
  • Industry
  • CRMD Biotechnology: Pharmaceutical Preparations
  • TXO Oil & Gas Production
  • Sector
  • CRMD Health Care
  • TXO Energy
  • Exchange
  • CRMD Nasdaq
  • TXO Nasdaq
  • Market Cap
  • CRMD 849.8M
  • TXO 806.1M
  • IPO Year
  • CRMD 2010
  • TXO 2023
  • Fundamental
  • Price
  • CRMD $13.18
  • TXO $14.87
  • Analyst Decision
  • CRMD Strong Buy
  • TXO
  • Analyst Count
  • CRMD 6
  • TXO 0
  • Target Price
  • CRMD $15.00
  • TXO N/A
  • AVG Volume (30 Days)
  • CRMD 1.7M
  • TXO 453.9K
  • Earning Date
  • CRMD 05-06-2025
  • TXO 05-01-2025
  • Dividend Yield
  • CRMD N/A
  • TXO 15.91%
  • EPS Growth
  • CRMD N/A
  • TXO N/A
  • EPS
  • CRMD 0.28
  • TXO 0.40
  • Revenue
  • CRMD $82,553,827.00
  • TXO $299,696,000.00
  • Revenue This Year
  • CRMD $238.38
  • TXO $27.46
  • Revenue Next Year
  • CRMD $53.52
  • TXO $4.03
  • P/E Ratio
  • CRMD $47.48
  • TXO $36.93
  • Revenue Growth
  • CRMD N/A
  • TXO 3.43
  • 52 Week Low
  • CRMD $3.61
  • TXO $14.78
  • 52 Week High
  • CRMD $13.85
  • TXO $22.39
  • Technical
  • Relative Strength Index (RSI)
  • CRMD 69.49
  • TXO 30.83
  • Support Level
  • CRMD $11.88
  • TXO $14.85
  • Resistance Level
  • CRMD $12.90
  • TXO $15.15
  • Average True Range (ATR)
  • CRMD 0.55
  • TXO 0.42
  • MACD
  • CRMD -0.07
  • TXO 0.01
  • Stochastic Oscillator
  • CRMD 90.00
  • TXO 9.38

About CRMD CorMedix Inc.

Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.

About TXO TXO Partners L.P.

TXO Partners LP is focused on the acquisition, development, optimization, and exploitation of oil, natural gas, and natural gas liquid reserves in North America.

Share on Social Networks: